Type 2 Diabetes
Conditions
Brief summary
This is a cross-sectional study planned among patients with Type 2 Diabetes (T2D) and Health Care Providers (HCPs) who treat T2D patients. Study participants will be recruited through existing databases/panels to complete a 30-minute self-administered online survey. The purpose of the study is to understand the insulinization barriers and the insulin adherence behaviours of both HCPs and patients.
Interventions
OTHERNo treatment given
No treatment given
Sponsors
Novo Nordisk A/S
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
For patients 1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol). 2. Male or female, age above or equal to 18 years at the time of signing informed consent. 3. Diagnosed with T2D 4. Currently seeing an HCP for T2D 5. Initiated on insulin within the past 12 months 6. Prescribed insulin on a permanent basis 7. Currently taking insulin via a vial and syringe or insulin pen For HCP 1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol). 2. Male or female, age above or equal to 18 years at the time of signing informed consent. 3. Primary care physician (PCP) with degree in internal medicine or general medicine, diabetologist with degree in internal medicine or general medicine plus diploma in diabetology, or endocrinologist 4. Has been in practice a minimum of 2 years 5. Diabetologist/endocrinologist: treats at least 50 T2D patients per month 6. PCP: treats at least 40 T2D patients per month 7. Currently initiates T2D patients on insulin 8. Treats 20 percent or more of T2D patients with insulin
Exclusion criteria
1. Previous participation in this study. Participation is defined as having given informed consent in this study 2. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The barriers toward insulin initiation among HCPs & patients | At time of data abstraction (Day 1) | Barriers to insulin initiation = Likert scale: 1=Strongly disagree, 5=Strongly agree |
Countries
India
Outcome results
None listed